The United States shows the highest mortality rate for blood and blood-forming organs diseases among the listed countries, with a marginal increase of 0.79% year-on-year. Latin American countries like Colombia and Mexico experience rising mortalities, potentially due to developing healthcare infrastructures. Meanwhile, European countries such as Latvia and Slovakia report significant decreases in death rates, indicative of improved medical interventions and healthcare systems. Stable or slight negative growth in Western European nations and Canada suggests well-established healthcare systems managing these diseases effectively.
Future trends to watch include:
- Technological advancements in treatment and early diagnosis could further reduce mortality rates globally.- Emerging health policies and access to healthcare will play crucial roles, especially in developing countries with higher mortality.- Close monitoring of demographic shifts, as aging populations in developed regions could impact disease prevalence and mortality.- Implementation of global health initiatives may bring focused efforts on disease management and reduction across different regions.
Top countries in Blood and Blood-Forming Organs Diseases Mortality by Country
| # | 10 Countries | Units (Female Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 6,110 | 2023 | +0.88% | +0.79% | View data |
| 2 | 2 South Africa | 4,160 | 2023 | -4.19% | -3.25% | View data |
| 3 | 3 Brazil | 3,460 | 2023 | +0.84% | +0.24% | View data |
| 4 | 4 Mexico | 2,640 | 2023 | -0.49% | +2.83% | View data |
| 5 | 5 Japan | 2,450 | 2023 | +0.86% | +0.45% | View data |
| 6 | 6 Spain | 1,240 | 2023 | +1.3% | +3.25% | View data |
| 7 | 7 Argentina | 909 | 2023 | +5.21% | +3.08% | View data |
| 8 | 8 Colombia | 684 | 2023 | +4.75% | +12.3% | View data |
| 9 | 9 United Kingdom | 670 | 2023 | -1.03% | -0.35% | View data |
| 10 | 10 Peru | 582 | 2023 | +1.78% | +2.65% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...